
Journal of Antibiotics p. 676 - 682 (1995)
Update date:2022-09-26
Topics:
Paris
Francois
Molherat
Albano
Robin
Vuilhorgne
Barriere
Pristinamycin I(A) was modified in a two-step procedure to give original derivatives possessing a tricyclic nucleus (8a, 8b, 8c) or a substituted pyrrole ring (10a, 10b) in place of the natural exocyclic 3-hydroxy-picolinoyl residue. This transformation involved firstly preparation of pyridinium betaines 5 from pristinamycin I(A) and secondly a 1~3 dipolar cycloaddition between 5 and N-substituted maleimides or diethyl acetylenedicarboxylate. The compounds obtained were evaluated as antibacterial agents alone and in association with pristinamycin II(A).
View Morejintan yufan Medicine Raw materials Co.,Ltd.(expird)
Contact:86-519-82808282
Address:6th,Jincheng Huangzhuang
Taimai Sanluck Pharmaceutical Co.,Ltd
Contact:86-592-7662921
Address:8D,No.186,Huarong Road,Huli,Xiamen,China
Contact:86-532-68629711 13780605697
Address:NO 220 YANAN 3 ROAD,(POST ADMINISTRATION BUILDING),QINGDAO,CHINA
Winchem Industrial Co. Ltd.(expird)
Contact:86-574-83851061 86-574-87083208
Address:Room 905, No.3 Building,East Business Center, 456 Xingning Road, Ningbo City,China
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Doi:10.1039/DT9950003691
(1995)Doi:10.1021/om950457v
(1996)Doi:10.1080/17415993.2013.765429
(2013)Doi:10.1016/S0040-4039(00)76955-3
(1994)Doi:10.1016/0040-4039(95)02019-L
(1995)Doi:10.1016/S0040-4020(01)92099-X
(1981)